NYSE - Delayed Quote • USD
agilon health, inc. (AGL)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 5:32 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 12 | 12 | 13 | 12 |
Avg. Estimate | -0.01 | -0.06 | -0.31 | -0.19 |
Low Estimate | -0.08 | -0.13 | -0.52 | -0.46 |
High Estimate | 0.09 | 0.02 | -0.06 | 0.2 |
Year Ago EPS | 0.04 | -0.04 | -0.64 | -0.31 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 16 | 16 | 17 | 17 |
Avg. Estimate | 1.6B | 1.6B | 6.5B | 8.07B |
Low Estimate | 1.47B | 1.51B | 6.1B | 7.55B |
High Estimate | 1.63B | 1.63B | 8.23B | 9.42B |
Year Ago Sales | 1.14B | 1.15B | 4.32B | 6.5B |
Sales Growth (year/est) | 41.10% | 39.10% | 50.60% | 24.10% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | 0.02 | -0.02 | -0.06 | -0.3 |
EPS Actual | 0.04 | -0.04 | -0.08 | -0.57 |
Difference | 0.02 | -0.02 | -0.02 | -0.27 |
Surprise % | 100.00% | -100.00% | -33.30% | -90.00% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.01 | -0.06 | -0.31 | -0.19 |
7 Days Ago | -0.01 | -0.06 | -0.31 | -0.19 |
30 Days Ago | -0.01 | -0.05 | -0.3 | -0.18 |
60 Days Ago | 0.03 | -0.01 | -0.11 | 0.04 |
90 Days Ago | 0.02 | -0.01 | -0.08 | 0.08 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | AGL | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -125.00% | -- | -- | 5.40% |
Next Qtr. | -50.00% | -- | -- | 10.90% |
Current Year | 51.60% | -- | -- | 4.50% |
Next Year | 38.70% | -- | -- | 13.10% |
Next 5 Years (per annum) | -657.60% | -- | -- | 10.94% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Initiated | Citigroup: Neutral | 4/22/2024 |
Initiated | Barclays: Underweight | 3/6/2024 |
Maintains | Truist Securities: Hold to Hold | 2/29/2024 |
Maintains | Benchmark: Buy to Buy | 2/29/2024 |
Maintains | Evercore ISI Group: In-Line to In-Line | 2/28/2024 |
Maintains | RBC Capital: Outperform to Outperform | 2/28/2024 |
Related Tickers
LFST LifeStance Health Group, Inc.
6.20
+0.65%
SGRY Surgery Partners, Inc.
24.55
-1.17%
PIII P3 Health Partners Inc.
0.4462
-7.02%
AUNA Auna SA
7.06
-1.81%
FMS Fresenius Medical Care AG
20.10
-0.54%
CHE Chemed Corporation
560.42
-2.25%
ASTH Astrana Health, Inc.
36.72
+0.44%
BACK IMAC Holdings, Inc.
3.9200
-23.14%
ACHC Acadia Healthcare Company, Inc.
73.59
+0.29%
HCA HCA Healthcare, Inc.
306.69
-2.37%